Structure (Nic02 0000 01)
Nicardipine Hydrochloride Injection
Product Images NDC 65219-818
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride (NDC 65219-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Nic02 0000 02)
Principal Display Panel – Vial Label (Nic02 0000 03)
This is a description about Nicardipine Hydrochloride Injection. It is a prescription medication that should be diluted before infusion and discarded if unused. The solution is for intravenous use only. Each 10 mL vial contains 25 mg of nicardipine hydrochloride, and should be stored at 20° to 25°C. It also includes benzoic acid and sodium chloride in Water for Injection. The package insert provides instructions for the usual dosage. This product is manufactured by Fresenius Kabi in China.*
Principal Display Panel – Individual Carton (Nic02 0000 04)
This text provides information about a pharmaceutical product in the form of a 10 mL vial containing 25 mg of nicardipine hydrochloride, along with other components. It advises on proper usage, storage conditions, and warnings about ensuring the integrity of the vial before use. The product is a niCARdipine Hydrochloride Injection intended for intravenous use, with the necessity of dilution before infusion. It also indicates the manufacturer's details and features a data matrix code for tracking.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
